arrow
L

Luís Téllez

Gastroenterology and Hepatology Department
H指数:29
被引数:6,404

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD

使用非侵入性检测预测当代多中心队列中cACLD患者的肝功能失代偿

2025-11-040
PRE
Early portopulmonary hypertension predicts mortality in patients with cirrhosis: insights from the PORTO-DETECT cohort

早期门肺高血压可预测肝硬化患者的死亡率:PORTO-DETECT队列研究的结果

2025-10-100
PRE
Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis

对于同时患有急性静脉曲张出血和严重酒精性肝病的危重患者,应考虑进行预防性TIPS治疗。

2025-09-290
OAAI
Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study

利伐沙班预防肝硬化门静脉高压并发症:CIRROXABAN研究

2025-07-190
PRE
Non-invasive assessment of severe liver fibrosis in patients with Fontan-associated liver disease: The VALDIG-EASL FONLIVER cohort

Fontan相关肝病患者严重肝纤维化的非侵入性评估: VALDIG-EASL FONLIVER队列

2025-03-013
PRE
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study
2024-12-012
PRE
Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study

SARS-CoV-2疫苗接种对血管性肝病患者的影响: 来自VALDIG多中心研究的观察

2024-12-010
OAAI
Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD

肝静脉压力梯度预测MASLD患者肝功能失代偿和肝脏相关死亡率的风险

2024-11-014
OAAI
Persistent varices in cured patients: Understanding the role of hepatic venous pressure gradient
2024-10-010
OAAI
Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure
2024-10-010
PRE
Abdominal surgery in patients with chronic noncirrhotic extrahepatic portal vein obstruction: A multicenter retrospective study
2024-04-290
PRE
Non-invasive candidate protein signature predicts hepatic venous pressure gradient reduction in cirrhotic patients after sustained virologic response

非侵入性候选蛋白签名预测持续病毒学应答后肝硬化患者肝静脉压力梯度降低

2023-07-133
OAAI
Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis

抗凝治疗可改善肝硬化和门静脉血栓形成患者的生存率: IMPORTAL竞争风险荟萃分析

2023-07-0142
PRE
Increased sinusoidal pressure impairs liver endothelial mechanosensing, uncovering novel biomarkers of portal hypertension

增加的正弦压力损害肝内皮机械传感,揭示门静脉高压症的新生物标志物

2023-06-0113
OAAI
Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome

肝移植治疗门窦血管性肝病: 长期结果

2023-05-2312
OA